Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Precision Biosciences Inc
(NQ:
DTIL
)
9.690
-0.030 (-0.31%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Precision Biosciences Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
SPX, Nasdaq Look To Continue Rally
March 01, 2024
Fresh off a fourth-straight monthly win on Wall Street, stocks are on the rise as the week winds down.
Via
Talk Markets
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 01, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
March 01, 2024
Pre-market stock movers are worth checking on Friday as investors prepare for the last day of trading this week with all of the latest news!
Via
InvestorPlace
Precision BioSciences Announces $40.0 Million Offering of Common Stock and Warrants
March 01, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Earnings Outlook For Precision BioSciences
November 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 29, 2024
Via
Benzinga
Precision BioSciences Announces Proposed Public Offering of Common Stock and Warrants
February 29, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 27, 2024
Via
Benzinga
Precision BioSciences Announces Non-Exclusive Patent License Agreement with Caribou Biosciences
February 20, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Receives Pre-IND Feedback from US FDA for PBGENE-HBV as it Advances Towards Clinical Readiness
February 14, 2024
From
Precision BioSciences
Via
Business Wire
Precision BioSciences Promotes Naresh Tanna to Vice President of Investor Relations
February 13, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Receives Initial $7.5 Million Cash Payment and Equity Investment from TG Therapeutics for Azel-Cel in Treatment of Autoimmune Diseases
February 12, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Effect a Reverse Stock Split
February 09, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 30, 2024
Via
Benzinga
Why Is Multiple Sclerosis Focused TG Therapeutics Stock Trading Higher Today?
January 10, 2024
TG Therapeutics Inc (NASDAQ: TGTX) reported preliminary BRIUMVI U.S.
Via
Benzinga
Why Precision BioSciences Stock Is Up Today
January 09, 2024
Precision BioSciences, Inc. (NASDAQ: DTIL) shares are trading higher Tuesday after the company announced it has signed a licensing agreement wit
Via
Benzinga
Precision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseases
January 09, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Approval of First Clinical Trial Application of ARCUS Gene Insertion Program by Partner iECURE
December 13, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 05, 2023
Via
Benzinga
Precision BioSciences Announces Publication in Nature Metabolism Supporting ARCUS® In Vivo Gene Editing as a Potentially Curative Treatment for Mitochondrial Diseases
December 04, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Present at Hep-DART 2023
November 30, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
November 28, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Sidoti Events, LLC’s Virtual November Micro-Cap Conference
November 14, 2023
Via
ACCESSWIRE
Precision BioSciences Presents Late-Breaking Data Highlighting Preclinical Efficacy and Safety of PBGENE-HBV for Chronic Hepatitis B at AASLD’s The Liver Meeting 2023
November 13, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Present at Upcoming Sidoti Conference
November 10, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Late-Breaking Poster Presentation at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting
November 09, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Reports Third Quarter 2023 Financial Results and Provides Business Update
November 07, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 01, 2023
Via
Benzinga
Precision BioSciences to Report Third Quarter Results on November 7, 2023
November 01, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Presents Preclinical Data Highlighting Capabilities of ARCUS for Gene Insertion and Excision at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress
October 26, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.